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Abstract Brief periods of ventricular pacing during the
early reperfusion phase (pacing-induced postconditioning,
PPC) have been shown to reduce infarct size as measured
after 2 h of reperfusion. In this study, we investigated (1)
whether PPC leads to maintained reduction in infarct size,
(2) whether abnormal mechanical load due to asynchro-
nous activation is the trigger for PPC and (3) the signaling
pathways that are involved in PPC. Rabbit hearts were
subjected to 30 min of coronary occlusion in vivo, fol-
lowed by 6 weeks of reperfusion. PPC consisted of ten 30-s
intervals of left ventricular (LV) pacing, starting at
reperfusion. PPC reduced infarct size (TTC staining) nor-
malized to area at risk, from 49.0 ± 3.3% in control to
22.9 ± 5.7% in PPC rabbits. In isolated ejecting rabbit
hearts, replacing LV pacing by biventricular pacing abo-
lished the protective effect of PPC, whereas ten 30-s periods
of high preload provided a protective effect similar to PPC.
The protective effect of PPC was neither affected by the
adenosine receptor blocker 8-SPT nor by the angiotensin II
receptor blocker candesartan, but was abrogated by the
cytoskeletal microtubule-disrupting agent colchicine.
Blockers of the mitochondrial KATP channel (5HD), PKC
(chelerythrine) and PI3-kinase (wortmannin) all abrogated
the protection provided by PPC. In the in situ pig heart,
PPC reduced infarct size from 35 ± 4t o1 6± 12%, a
protection which was abolished by the stretch-activated
channel blocker gadolinium. No infarct size reduction was
achieved if PPC application was delayed by 5 min or if
only ﬁve pacing cycles were used. The present study
indicates that (1) PPC permanently reduces myocardial
injury, (2) abnormal mechanical loading is a more likely
trigger for PPC than electrical stimulation or G-coupled
receptor stimulation and (3) PPC may share downstream
pathways with other modes of cardioprotection.
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Introduction
During the last 5 years, it has become evident in animals
[51] as well as patients [34, 37] that interventions during
the early reperfusion phase (postconditioning) can reduce
the injury induced by the combination of ischemia
and reperfusion. The conventional way to induce
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after onset of reperfusion (ischemic postconditioning,
IPoC). This method of protection has been shown to be
triggered primarily by activation of adenosine receptors,
to be mediated via Gi-coupled receptors (for review see
[41]) and ultimately to lead to prevention of the opening
of the mitochondrial permeability transition pore (mPTP)
[1]. Several drugs can also induce postconditioning
through Gi-coupled receptors, like bradykinin, anesthetics
and opioids [41], whereas cyclosporine induces post-
conditioning by directly inhibiting the mPTP [1].
Our laboratory recently demonstrated that brief periods
of ventricular pacing at essentially unchanged heart rate
can also elicit myocardial protection during the early
reperfusion phase [39]. This pacing-induced postcondi-
tioning (PPC) was demonstrated in the isolated rabbit heart
as well as in the in vivo pig heart. For potential future
clinical use, it is important to know whether PPC not only
reduces infarct size after a few hours of reperfusion, but
also in the long term. This question is important because
studies have shown that reperfusion injury continues to
develop for several days [19, 25, 52].
Moreover, it is of utmost importance to understand the
mechanisms of PPC. Previous animal studies showed that
ventricular pacing prior to ischemia (preconditioning) and
in the early reperfusion phase (postconditioning) did not
change myocardial blood ﬂow or lactate release. This
suggested, but did not prove, that ischemia is not a trigger
for pacing preconditioning and PPC [39, 40]. In addition,
PPC was demonstrated in isolated hearts with constant
preload, afterload and heart rate, excluding these factors
as potential triggers [39]. This information indicates that
PPC, like IPoC, provides protection through endogenous
mechanisms, but using at least partially different path-
ways than IPoC. Better understanding of all pathways that
potentially lead to protection of the heart may provide
approaches for more effective therapy during the early
reperfusion phase.
Therefore, the aims of the present study were to inves-
tigate the long-term protection by PPC as well as its
mechanisms. With respect to the latter, we hypothesized
that abnormal myocardial mechanical load, induced by the
dyssynchronous contraction during pacing, is the trigger
for PPC. Of special interest seems to be the early systolic
stretch in regions remote from the pacing site (late-acti-
vated regions) [26, 27]. To investigate the importance of
stretch as trigger for PPC, we compared the protective
effect of single ventricular (dyssynchronous) and biven-
tricular (relatively synchronous) pacing and that of
increased global ventricular preload without pacing.
Moreover, it was investigated to what extent the protective
effect of PPC is abolished by a blocker of stretch-activated
channels (SACs), disruption of microtubule stretch-
mediated signaling and blockers of various receptors and
signaling pathways, involved in other modes of postcon-
ditioning (adenosine, phosphatidylinositol-3 kinase (Pi3K),
protein kinase C (PKC) and the mitochondrial KATP
channel (mito KATP). Studies were performed in rabbit as
well as pig hearts because we previously showed the efﬁ-
cacy of PPC in both species [39].
Materials and methods
Rabbit heart experiments
Animal handling and treatment were according to the
Dutch law on animal experimentation (WOD). The pro-
tocol was approved by the Animal Ethical Committee of
Maastricht University. Female white New Zealand rabbits
(SPF bred, Harlan, France) were used for all rabbit
studies.
Long-term PPC studies in rabbits
Anesthesia was induced with ketamine (15 mg/kg, I.M.)
and diazepam (0.5 mg/kg, I.M.) and maintained by I.V.
infusion of sufentanyl (0.5–2 lg/kg/min), diazepam (1 mg/
kg/4 h) and ventilation with isoﬂurane (0.5–1.0%). After
opening the chest, the left descending coronary artery was
isolated and ligated using a 3–0 suture for an ischemic
period of 30 min. In the PPC group, PPC was applied
starting 30 s after opening the vessel and applying ten 30-s
periods of pacing (at 30-s non-paced intervals) at the LV
free wall, posterior from the previously ischemic region
(VOO pacing mode, *10% above the sinus rhythm). The
chest was closed after 1 h of reperfusion. In the control
group, no other intervention than reperfusion was per-
formed. All animals were allowed to recover after closing
the chest, anesthesia was stopped and the animals were
returned to their cages.
The effect of myocardial infarction and PPC on LV
geometry was determined using 2D echocardiography
before and every 2 weeks after myocardial infarction. To
this purpose, short-axis views at mid-papillary level were
recorded in the conscious state using an ESAOTE Megas
ultrasound System and a 5–7.5 MHz transducer.
After 6 weeks, the animals were anesthetized again and
hemodynamic measurements were performed using a 4F
Millar pressure transducer. All signals (ECG, pressure)
were digitized at 1 kHz and stored using custom-made
software (IDEEQ, Maastricht Instruments, The Nether-
lands) and later analyzed using custom software.
Finally, the heart was arrested and infarct size was
determined using methylene blue and triphenyl tetrazolium
chloride (TTC) staining as previously described [39].
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After sedating the animals with intramuscular ketamine
(50 mg/kg) and xylazine (5 mg/kg), hearts were isolated
and attached to the perfusion apparatus as described in
more detail by Vanagt et al. [40]. Brieﬂy, the aorta and a
pulmonary vein were cannulated to allow antegrade per-
fusion (ejecting mode) of the isolated heart. The heart was
instrumented with epicardial pacing electrodes on the right
atrial (RA) appendage and on the posterior basal left ven-
tricular (LV) wall. In the case of biventricular (BiV) pac-
ing, another pacing electrode was positioned on the right
ventricular (RV) free wall. A silastic catheter to measure
LV pressure was introduced into the LV through the LV
apex. Throughout the experiment, the preload was kept
constant at 6 mmHg (except in the high preload group, see
below), afterload at 80 mmHg and heart rate at 240 bpm
(physiological heart rate for rabbits [3]).
All hearts experienced 30 min of coronary occlusion,
followed by 2 h of reperfusion (Fig. 1). Hearts subjected to
PPC additionally underwent ten cycles of 30 s ventricular
pacing on/30 s ventricular pacing off (except when men-
tioned otherwise). Ventricular pacing was performed using
simultaneous atrio-ventricular pacing (atrio-ventricular
interval = 0 ms) to insure complete ventricular activation.
BiV pacing was achieved by simultaneous LV and RV
pacing. In the high preload group, preload was increased
from 6 to 12 mmHg by raising the atrial reservoir in the
working heart model using ten cycles of 30 s high preload
and 30 s of normal preload.
In groups where drugs were administered to investigate
involvement of their target in PPC, the hearts were per-
fused with drug containing medium between 5 min prior to
onset of reperfusion and 10 min after start of reperfusion
(the end of the PPC sequence, Fig. 1). Due to the non-
recirculating perfusion system used, drug levels in the
perfusion medium can be expected to have decreased to
zero within a few minutes.
All drugs, 8-(p-sulfophenyl)theophylline (8-SPT,
100 lmol/l), candesartan (10 nmol/l), 5-hydroxydecanoate
(5-HD, 100 lmol/l), chelerythrine (5 lmol/l), wortmannin
(100 nmol/l) and colchicine (50 lmol/l) were obtained
from Sigma–Aldrich (St. Louis, Missouri). These drugs and
the doses used have previously been shown to selectively
block their target by several others [7, 24, 35, 45, 48].
Collection of hemodynamic data and infarct size deter-
mination (TTC staining) were similar to the ones used in
our previous study [40].
In vivo swine hearts
Swine studies were performed in accordance with the
National Institutes of Health Guidelines for the Care and
Use of Laboratory Animals. The protocol was reviewed
and approved by the Boston Scientiﬁc Institutional Animal
Care and Usage Committee (Boston Scientiﬁc Corp., St.
Paul, MN, USA). A total of 26 domestic female swine were
randomly assigned to control (C), pacing post-conditioning
using ten 30-s cycles (PPC-10), ﬁve 30-s cycles (PPC-5),
5 min delayed PPC-10 (PPC-10D) and PPC with gadolin-
ium (PPC?Gd). Group size was 5, except for the PPC-10
group (n = 6). Gadolinium is a potent inhibitor of stretch-
activated channels in the myocardium [4, 9] and has been
shown to block volume overload-induced cardioprotection
in other animal models [8, 22].
The procedure was conducted in a closed chest model of
balloon-induced myocardial infarction. A surgical plane of
anesthesia was maintained with isoﬂurane (1.5–2.5%).
Two bi-polar endocardial pacing leads (Fineline II, Boston
Scientiﬁc Corp, St. Paul, MN, USA) were introduced
transvenously and positioned in the right atrium and RV
apex. An 8 Fr introducer sheath (Super Sheath, Boston
Scientiﬁc Corp, St. Paul, MN, USA) was surgically inser-
ted into a femoral artery using the Seldinger technique. A
6–8 Fr guide catheter (Boston Scientiﬁc Corp, St. Paul,
MN, USA) was advanced into the femoral artery and the
ostium of the catheter was positioned near the ostium of the
left main coronary artery. An initial angiogram was taken
to measure the diameter of the left anterior descending
artery (LAD) for determining the appropriate occlusion
Control
PPC
PPC + 
Drugs
High 
Preload
30 min ischemia
30”
V-pacing
30”
high preload
2 hours 
reperfusion
Drug infusion
2 hours 
reperfusion
2 hours 
reperfusion
2 hours 
reperfusion
Fig. 1 Experimental protocol for studying the role of abnormal
mechanical load and electrical stimulation in isolated rabbit hearts.
Regional ischemia was induced by coronary ligation for 30 min. The
heartswereatriallypacedat240 bpmduringtheentireprotocol,except
duringtheﬁrst10 minofreperfusion(grayblocks),wheresimultaneous
atrial and LV posterior wall (or biventricular in one series) pacing at
240 bpm was performed. Drug infusion was started 5 min before the
startofreperfusionandwascontinuedtilltheendofLVpacing.Theten
open blocks in the high preload group indicate the periods with
increased preload (from 6 to 12 mmHg) by raising the atrial reservoir
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Scientiﬁc Corp, St. Paul, MN, USA) was positioned distal
to the ﬁrst branch of the LAD as deemed necessary for
creating an infarct of appropriate size. After 30 min of a
stabilization period, coronary artery occlusion was induced
by inﬂation of the balloon catheter. The occlusion was
conﬁrmed by ﬂuoroscopy performed several times during
the occlusion period. After 60 min of occlusion, the bal-
loon was rapidly deﬂated, followed by 3 h of reperfusion.
In all pacing protocols, right ventricular (RV) pacing was
performed in the VVI mode (ventricular sense–ventricular
pace, inhibit) 20–30 beats above sinus rhythm (SR). In the
control group, hearts were allowed to beat in SR throughout
the experiment. In the PPC-10 and PPC-5 groups, postcon-
ditioning was initiated exactly 30 s after the deﬂation of the
balloon, using ten or ﬁve cycles of 30 s of RV pacing fol-
lowed by 30 s of normal SR, respectively (Fig. 2). In the
delayed PPC (PPC-D) group, the pacing sequence was ini-
tiated 5 min after the balloon was deﬂated. In the PPC?Gd
group,attheendoftheindexischemia,Gd
3?(40 lmol)was
injected into the left main artery via the guide catheter
throughout the entire 10-min PPC period. In all groups, the
reperfusion period was 3 h, after which the animal was
overdosed with isoﬂurane. Thereafter, methylene blue and
TTC staining were performed as previously described [39].
Area of infarct, area at risk and total LV area were deter-
mined using ImageJ (NIH, Bethesda, MA, USA).
Statistical analysis
Data are expressed as mean ± SD. Unpaired two-sided t
tests were used to test for differences in infarct size
between groups. Repeated measures one-way analysis of
variance (ANOVA), followed by Bonferroni post hoc tests,
were used to evaluate hemodynamic changes over time.
P\0.05 was considered to be statistically signiﬁcant.
Results
Long-term PPC studies
Infarct size (relative to area at risk, AAR) was
49.0 ± 8.6% in the controls (n = 5) and 22.9 ± 15.0% in
the PPC rabbits (n = 7), (P = 0.006, Fig. 3). The area at
risk was not signiﬁcantly different at 41.6 ± 6.9 and
38.5 ± 5.7% of the LV, respectively. Two weeks after the
index ischemia, a signiﬁcant decrease in fractional short-
ening was observed in the control group, but not in the PPC
group. LV end-diastolic diameter showed a sustained sig-
niﬁcant increase in both groups during the weeks following
the infarction, but this increase tended to be smaller in the
PPC group (Fig. 4). Invasive hemodynamic measurements
after 6 weeks of infarction did not show a signiﬁcant dif-
ference between the groups with regard to heart rate, sys-
tolic and end-diastolic blood pressure and the maximal rate
of rise of LV pressure, LVdP/dtmax (data not reported).
Isolated rabbit hearts
There was no signiﬁcant difference in body weights and
heart weights between the study groups. The area at risk of
the LV was also not signiﬁcantly different between any of
the study groups (Table 1).
reperfusion
3 hours 
Control
30 min ischemia
30”
V-pacing
PPC
10x30
PPC + 
Gd3+
Gd3+ infusion
PPC
Delayed
PPC
5x30
Fig. 2 Experimental protocol for the in vivo studies of pig hearts.
The format is equal to that of Fig. 1
Fig. 3 Infarct size, normalized for the area at risk, in rabbit hearts
6 weeks after the ischemia/reperfusion procedure (left) and represen-
tative hearts (right). Open bar represents controls and ﬁlled bar
represents PPC
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At baseline during RA pacing, cardiac output and LVdP/
dtmax were similar in all groups. These variables were also
not signiﬁcantly different between the groups at any time
point during the protocol (Table 2). In all groups, during
and after ischemia, cardiac output and LVdP/dtmax were
signiﬁcantly depressed as compared with baseline. During
early reperfusion in the PPC groups, LV pacing caused a
moderate reduction in cardiac output and LVdPdtmax as
compared with RA pacing (Table 2). In the BiV PPC
group, biventricular pacing did not lead to a signiﬁcant
decrease in hemodynamic parameters as compared to atrial
pacing. In the high preload group, hemodynamic indices
increased signiﬁcantly during the episodes with high pre-
load as compared to those with normal preload. None of
the drugs had a signiﬁcant effect on hemodynamics
(Table 2).
Infarct size reduction
Similar to our previous study [39], single site pacing at the
LV wall (PPC) resulted in a signiﬁcant reduction in infarct
size (26 ± 5 vs. 47 ± 3% in the control group). LV pacing
in the early reperfusion phase was shown to lead to sig-
niﬁcant redistribution of mechanical load and abnormal
patterns of shortening and stretch within the LV wall [27,
39]. In the high preload group, a higher workload in the
absence of any ventricular pacing (evidenced by increased
cardiac output at ﬁxed afterload and heart rate) was asso-
ciated with a similar protection (infarct size 23 ± 2%) as
compared to PPC. In contrast, biventricular pacing, known
to lead to much smaller regional contraction abnormalities
than LV pacing [43], did not provide signiﬁcant protection
(infarct size 51 ± 2%, Fig. 5; Table 2).
Figure 5 also shows that the adenosine receptor blocker
8-SPT did not abolish the PPC-induced protection
(25 ± 7%). These data indicate that this autocrine factor,
released by the myocardium during ischemia, is not
involved in PPC. In contrast, the microtubule-disrupting
agent colchicine abolished the PPC-induced protection
(53 ± 2%, Fig. 5), suggesting a role for the cytoskeleton in
PPC.
The blockers of PKC, PI3K and mitochondrial KATP
(chelerythrine, wortmannin and 5-HD, respectively) all
abrogated the protective effect of PPC (45 ± 4, 50 ± 4
and 49 ± 5%, respectively), thus providing evidence that
these signaling processes, known to be involved in IPoC,
are also involved in PPC (Fig. 5).
Algorithm for PPC
To investigate what combination of duration and number of
pacing cycles provides protection, experiments were per-
formed where, in addition to the 10 9 3000 pacing protocol,
also 10 9 2000 and 10 9 1000 as well as 5 9 3000,59 2000
and 5 9 1000 pacing was performed. Figure 6 displays the
infarct size achieved using the various pacing algorithms,
plotted as a function of the total duration of pacing.
Algorithms using ten cycles of ventricular pacing resulted
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Table 1 Number of experiments per group, body weight (kg), heart
weight, area at risk (% of LV) and infarct size (% of area at risk) in
the various groups of isolated rabbit hearts
Group n Body
weight
Heart
weight
Area at
risk
Infarct
size
Control 9 3.02 ± 0.61 8.46 ± 0.75 54 ± 64 7 ± 3
Paced 8 3.03 ± 0.35 8.60 ± 0.45 51 ± 62 6 ± 5*
BiV pacing 4 2.45 ± 0.31 7.61 ± 0.53 53 ± 25 1 ± 2
Preload 4 3.50 ± 0.42 8.20 ± 0.63 48 ± 32 3 ± 2*
8-SPT 5 2.76 ± 0.71 8.46 ± 1.35 55 ± 52 5 ± 7*
Colchicine 6 3.53 ± 0.21 8.73 ± 0.61 54 ± 11 53 ± 2
Candesartan 4 3.43 ± 0.11 8.45 ± 0.51 50 ± 42 0 ± 2*
5HD 6 2.83 ± 0.22 8.57 ± 0.44 57 ± 84 9 ± 5
Wortmannin 4 2.93 ± 0.43 8.78 ± 0.11 55 ± 95 0 ± 4
Chelerythrine 4 2.84 ± 0.20 7.94 ± 0.34 52 ± 84 5 ± 4
* P\0.05, as compared to control
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123in protection (circles), but no algorithms using ﬁve cycles
of pacing resulted in protection, not even if the total
duration of pacing was longer than that of the 10 9 1000
pacing protocol (Fig. 6).
Pig heart studies
In the in situ pig hearts, PPC reduced infarct size from
*35 to *16% of the area at risk, a relative reduction
similar to that in the rabbit hearts (Fig. 7). Applying only
ﬁve instead of ten pacing cycles provided less, and statis-
tically not signiﬁcant, protection than ten cycles. Starting
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123the ten pacing cycles as late as 5 min after onset of
reperfusion abrogated the protective effect of PPC com-
pletely. Similarly, administration of the SAC blocker
gadolinium completely abrogated the infarct size reduction
provided by PPC.
In the entire group of 26 animals, 8 experienced ven-
tricular ﬁbrillation (VF) during the occlusion period and 6
in the early reperfusion phase. With respect to the latter,
this concerned 2/5 animals in the control group, 2/6 in the
PPC, 0/5 in the PPC?Gd, 1/5 in the PPC-5 and 1/5 in the
PPC-D group. In all those cases, VF occurred during
the ﬁrst 2 min after the start of reperfusion. VF occurred in
the absence of pacing (control group) as well as before
onset of the pacing protocol (PPC-D group). Also, the two
cases of VF in the PPC group occurred immediately on
reperfusion, before starting the pacing protocol. All these
animals were successfully deﬁbrillated and their data were
included in the analysis.
Discussion
This study demonstrates that PPC achieves a maintained
reduction in infarct size, which will be of crucial impor-
tance for potential application in a clinical setting. The data
from the present study provide further evidence that
abnormal mechanical loading of the myocardium is a
trigger for the PPC-induced protection. SACs and micro-
tubules appear to play a role in transduction of the stretch
signal to more downstream located pathways, which appear
to be similar in PPC and other modes of postconditioning.
Long-term protection by PPC
The demonstration that PPC induces maintained reduction
in infarct size strongly indicates that PPC does not delay,
but actually diminishes, myocardial injury over the long
term. Long-term infarct size reduction has also been shown
in experimental [19] and clinical studies on IPoC [37]. The
present study, therefore, provides support for a potentially
clinically relevant, maintained protection by PPC in
patients. The smaller infarct size in the PPC animals was
associated with a lack of the transient decrease in fractional
shortening after 2 weeks of myocardial infarction, as
observed in the control animals. The absence of more
pronounced effect of the protection on cardiac geometries
may be due to the relatively small infarcts (*20% of LV
mass) and the ability to compensate for the loss of function,
as evidenced from the recovery of fractional shortening in
the control group. As reviewed by Miura and Miki [18],
also in patients a signiﬁcant effect on echocardiographic
parameters can only be expected when a considerable
reduction in infarct size is achieved.
Mechanisms of PPC
The lack of effect of the adenosine receptor blocker 8-SPT
on PPC provides further evidence that ischemia is not the
trigger for PPC. This evidence corroborates ﬁndings from
our previous study that ventricular pacing does not change
myocardial blood ﬂow or lactate release during normal
conditions or during early reperfusion [39]. Therefore, also
other mechanisms such as maintained acidosis [29] are not
expected to play a role. Because PPC was applied while
applying immediate and full reperfusion, the protection
afforded by PPC cannot be related to gradual reperfusion
and is a strong argument for postconditioning as a separate
entity [10].
Ventricular pacing markedly alters the myocardial
contraction pattern, leading to considerable regional dif-
ferences in mechanical load in vivo and in the isolated
working heart model [26, 27, 39, 40]. Since in our isolated
heart preparation many hemodynamic factors (heart rate,
global preload, global afterload) were kept constant, the
intermittent changes in regional mechanical loading are a
likely candidate to be the trigger for PPC. The abnormal
mechanics during ventricular pacing is characterized by
early systolic stretch in late-activated regions (those remote
from the pacing site). The idea that such stretch could elicit
protection is supported by the observation that intermit-
tently increasing global preload is also protective and that a
protective effect is absent when performing BiV pacing,
which is associated with less abnormal contraction patterns
than LV pacing [43]. These ﬁndings indicate that altera-
tions in workload of the myocardium, and not the artiﬁcial
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123electrical stimulation, have a protective effect. The lack of
protection in the BiV pacing group excludes the possibility
that the electrical stimulation may activate autonomic
cardiac nerves, thereby causing protection [2].
This study is also the ﬁrst to show that increased global
preload induces postconditioning, but earlier studies have
shown this for preconditioning [8, 22]. The abolishment of
PPC-induced protection by gadolinium indicates that SACs
may be involved in the transduction of the protective
stimulus. Gadolinium is a rather non-speciﬁc blocker of
SACs. Nevertheless, it has been shown to block cardio-
protection evoked by volume infusion before the index
ischemia (stretch-induced preconditioning) [8, 22]. This
ﬁnding supports the idea that PPC-induced protection
depends on myocardial stretch as a trigger or mediator.
This trigger should be applied in at least [5 cycles,
whereas the duration of each cycle is less important
(Figs. 6, 7). This observation indicates that the myocar-
dium may adapt quickly to the stretch stimulus.
The aforementioned stretch hypothesis is also supported
by the ﬁnding that the microtubule-disrupting agent colchi-
cine abolished PPC-induced reduction in infarct size.
Microtubules form a network of ﬁbers between sarcolemma
and nucleus (which is deformed when the myocyte is
deformed [21]) and play a key role in mechanotransduction.
Stretching of myocytes leads to release of angiotensin,
which is known to induce a hypertrophic response in the
myocyte through autocrine/paracrine effects. However, the
observation that the AT-1 blocker candesartan does not
reduce protection by PPC indicates that this mechanism
does not contribute importantly to the protective effect of
PPC.
Downstream pathways
In the present study, we used various pharmacological
blockers of pathways to explore their involvement in PPC.
This is a limitation of the study, because the blockers may
not be speciﬁc. Ultimate proof of a role of a pathway is
given by direct demonstration of activation of the pathway,
for example using Western blot analysis for degree of
phosphorylation. The main message from the present study
is not the involvement of one speciﬁc pathway in PPC, but
rather that PPC reacts in a similar fashion to several
blockers of classical downstream pathways of protection.
Therefore, these data indicate that, while upstream IPoC
and PPC show clear differences (no involvement of aden-
osine receptors in PPC), their downstream pathways may
be more similar.
PKC activation, shown in this study to be involved in
PPC, is also known as an important intermediate step in
protocols for IPoC [42]. In ischemic preconditioning, it has
been shown that PKC is most likely downstream of the
adenosine receptor, because the combination of PKC
activation and adenosine receptor blockade was protective,
whereas adenosine receptor activation in combination with
PKC blockade was not [13].
The Pi3K-Akt is another well-known pathway in car-
dioprotection and is also referred to as the RISK pathway.
This pathway is implemented in IPoC in rats and rabbits
[44]. However, its role in pigs is debated [30, 32]. In this
species, IPoC did not induce additional activation of RISK
or protection [32]. The abolishment of PPC-induced pro-
tection by wortmannin suggests involvement of the RISK
pathway in PPC. It should be recognized that a protection-
abolishing effect of wortmannin is not a direct proof of the
involvement of the RISK pathway. However, in the study
on involvement of the RISK pathway in pigs, a lack of
effect of wortmannin was associated with a lack of direct
involvement of the RISK pathway [32], whereas in a study
on the postconditioning effect of levosimendan the
increased phosphorylation of Akt and GSK-3b was
reversed completely in hearts that received wortmannin in
addition to levosimendan [12]. Therefore, wortmannin may
provide a fairly reliable prediction of involvement of the
RISK pathway in PPC in our setting of isolated rabbit
hearts. In the same experimental setting and species, Yang
et al. [44] also showed that wortmannin abolished protec-
tion by IPoC. So at least in the rabbit heart, PPC appears to
share the RISK pathway with IPoC.
The fact that we also observed protection by PPC in pigs
may suggest that (also) other pathways are involved. A
good candidate in this respect is the tumor necrosis factor
alpha (TNFa) pathway. Even brief periods of mechanical
stretch can induce rapid phosphorylation of JAK, STAT
and glycoprotein 130 [23]. TNFa-induced cardioprotection
does not rely on AKT and ERK1/2 [11] and TNFa is also
cardioprotective in pigs. [31].
The abolishment of the cardioprotective effect of PPC
by the selective mitoKATP channel blocker 5HD indicates
that opening of this channel is important in the cardio-
protection provided by PPC, similar to that provided by
IPoC. In ischemic preconditioning and postconditioning,
the mitoKATP channel has been assigned both a role as
trigger and as mediator [41, 47]. If the mitoKATP would
act as mediator in PPC, it may be activated by PKC and
Pi3K. A more direct involvement of mitoKATP in PPC
could be imagined to initiate from metabolic signals
originating from the mitochondria, the oxygen consump-
tion of which presumably change during each onset and
end of a cycle of ventricular pacing due to changes in
mechanical load [27].
Another downstream target of PI3K in PPC could be
HIF1a. In a recent study, HIF1a was shown to be related to
protection afforded by IPoC [49]. Moreover, increased wall
530 Basic Res Cardiol (2010) 105:523–533
123stress has been shown to increase HIF1a, using a SAC–
PI3K pathway [15].
Data from the pig heart studies demonstrate that PPC
should be applied within the ﬁrst 5 min after reperfusion. A
similar time window is known to exist for IPoC in rabbit
and human hearts [33].
Our ﬁnding that protection is achieved by ten, and not
by ﬁve, cycles of pacing in the pig heart are in line with the
data from Iliodromitis et al. [14], who found that protection
was achieved by eight and not four 30-s cycles of IPoC. It
is remarkable, however, that in the current study neither
application of ﬁve PPC cycles immediately after reperfu-
sion nor ten PPC cycles starting 5 min after reperfusion is
effective, but that adding ﬁve cycles of pacing after the ﬁrst
ﬁve cycles at the onset of reperfusion is required to provide
protection. This implies that the protective signaling pro-
cesses are not completed within 5 min of reperfusion and
need to be ampliﬁed by the second ﬁve pacing cycles.
Potential clinical application
PPC has the potential to be applied clinically. First of all,
the pacing hardware (pacing leads and pacemakers) has
already been developed and used in patients for many
years. Theoretically, PPC could be used in heart trans-
plantation cardiac surgery and percutaneous coronary
intervention conditions where beneﬁcial effects of IPoC
have been shown [16, 17, 34]. Moreover, a postcondi-
tioning algorithm could be implemented in implantable
devices, such as pacemakers and implantable cardioverter
deﬁbrillators. The latter option is unique for PPC.
Ventricular pacing may have the advantage over
‘‘classical’’ IPoC, in that it does not require mechanical
interaction with the already vulnerable coronary arterial
wall. PPC may be more complicated to ‘‘administer’’ than
drugs, but pacing and its side effects may be more easily
controllable, especially in the setting of percutaneous cor-
onary intervention.
An important issue is whether ventricular pacing in the
early reperfusion phase is proarrhythmic. During the early
reperfusion phase, the heart is susceptible to arrhythmia
and ectopic stimulation protocols are being used as provo-
cation tests for arrhythmias. However, in the present study
no evidence was found for a pro-arrhythmic effect. This is
notable, because pigs are known to be quite sensitive to
arrhythmias during ischemia/reperfusion experiments.
These ﬁndings may be explained by the use of the VVI
pacing mode, which inhibits stimulation when a sponta-
neous activation of the myocardium is sensed. Moreover,
pacing was performed at a regular rate, only slightly above
natural sinus rhythm. This is in contrast to arrhythmia
provocation tests, where stimulation is performed at a high
rate and/or at variable intervals. Clearly, further investi-
gation is required to assure the safety of PPC in a clinical
setting.
PPC may also be useful as an additive trigger for post-
conditioning, in conjunction with other postconditioning
approaches. It has been shown for example that the com-
bination of drugs and ischemic pre-conditioning has addi-
tive effects [20]. Such additive effect may be of particular
interest to patients with compromised hearts, who are
known to be more susceptible to myocardial damage and
less responsive to preconditioning and postconditioning
stimuli [6, 14, 36, 38, 50]. A study in ob/ob mice showed
reduced cardioprotection by IPoC, which was related to the
lack of phosphorylation of signaling molecules [5].
Application of modes of postconditioning with different
triggering mechanisms may be helpful in achieving sufﬁ-
cient levels of protection.
Finally, the ﬁnding that protection by PPC is indepen-
dent of the adenosine receptor may make this protection
insensitive to elevated plasma levels of caffeine. After all,
it has been shown that caffeine blocks the adenosine
receptor and that it also abolishes the protective effect on
ischemia/reperfusion damage by ischemic preconditioning
[28] and by statins [46]. Because caffeine is frequently
consumed and has a half-life of many hours, many patients
entering the hospital with a myocardial infarction may have
impaired potential to be protected by interventions, such as
IPoC and drugs like statins and bradykinin. PPC could be a
promising alternative, since it is independent of adenosine
receptors, as shown by the lack of effect of 8-SPT, which is
a caffeine derivate.
Conclusion
The present study shows that PPC, a recently discovered
mode of protection, results in maintained reduction of
infarct size and that abnormal mechanical load is the
trigger of the PPC-induced protection, presumably trans-
duced by stretch-activated channels. PPC shares down-
stream signaling pathways with other modes of
cardioprotection, such as PKC and PI3K activation. Inter-
estingly, however, adenosine and angiotensin receptors are
not involved in PPC-induced protection. Therefore, PPC
may be useful, because its effect is not hampered by caf-
feine and other G-protein signaling blocking substances.
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